Austin Biotech Firm XBiotech USA, Inc. Begins Construction On $200 Million Campus

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

XBiotech USA Inc., an emerging Austin drug developer, will break ground Friday on the first manufacturing and research facility at its 48-acre siteoff Riverside Drive in Southeast Austin that is expected to eventually house a $200 million campus of buildings.

The 46,0000-square-foot building will cost “no more than $12 million,” company President and CEO John Simard told Austin Business Journal. Construction is expected to finish by mid-2015 and start manufacturing and shipping the company’s colorectal cancer-fighting drug Xilonix by early 2016. That drug is currently going through Phase 3 trials in the U.S. and Europe.

Help employers find you! Check out all the jobs and post your resume.

Back to news